Cargando…
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
Autores principales: | Pérez-Plasencia, Carlos, Padilla-Benavides, Teresita, López-Urrutia, Eduardo, Campos-Parra, Alma D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269316/ https://www.ncbi.nlm.nih.gov/pubmed/34249767 http://dx.doi.org/10.3389/fonc.2021.713040 |
Ejemplares similares
-
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
por: López-Urrutia, Eduardo, et al.
Publicado: (2021) -
Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2020) -
Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer
por: López-Urrutia, Eduardo, et al.
Publicado: (2019) -
Editorial: Novel approaches to study metals in molecular biology
por: Padilla-Benavides, Teresita, et al.
Publicado: (2023) -
Alternative splicing regulation in tumor necrosis factor-mediated inflammation
por: López-Urrutia, Eduardo, et al.
Publicado: (2017)